Navigation Links
Pfizer Says Nigeria Gave Approval for 1996 Drug Test

US drug giant Pfizer Thursday said it had got the go-ahead from Nigerian authorities before administering a drug that claimed the lives of 11 children in the northern Kano state in 1996.

"We have written approvals from NAFDAC (Nigeria's drug agency), the federal ministry of health, Kano government and parents or guardians of the children before the clinical test of the drug was carried out," managing director of Pfizer Specialities Limited Nigeria Ngozi Edozien told reporters.

The Nigerian federal government and Kano state government have filed two separate suits against Pfizer, claiming around some 9.5 billion dollars in damages for victims of the failed drug test.

Both governments accuse Pfizer of administering a test antibiotic called Trovan without authorisation or parental consent among children at a field hospital during an epidemic of meningitis, measles and cholera.

Of the 200 children affected, 11 died while many more -- reportedly 181 -- suffered from deafness, paralysis, brain damage and blindness, according to the allegations. Pfizer denies the charges.

Edozien said Pfizer carried out the test following "an appeal for help" from Nigeria.

She said Trovan as an oral application was the best drug to treat those disease and underlined that Pfizer meant no harm.

The US Food and Drug Administration cleared Trovan for adult use in 1997 and the drug swiftly became established as one of the most prescribed antibiotics in the US market.

She said the company would defend itself against the suits during the next hearing.

The Nigerian federal government filed its suit on June 4 in Abuja for almost seven billion dollars in damages against the US drug firm, while Kano is asking for 2.5 billion dollars.

The federal suit comes up on July 20 while that of Kano government has been fixed for October 3.


'"/>




Page: 1

Related medicine news :

1. Pfizer unveils anti-smoking drug
2. The Effectiveness Of The Breast Cancer Drug By Pfizer
3. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
4. Erectile Dysfunction Drug Viagra Launched In India By Pfizer
5. Pfizer’s Eraxis Approved By The FD
6. Pfizer Launches Viagra For Lung Disease In UK
7. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
8. Pfizer Commences Its Advertising for Celebrex with All the Warnings
9. FDA Approves Pfizer’s Anti-smoking Dru
10. Pfizer vouches safety of long-term inhaled insulin.
11. NICE Setback Rules for Pfizers Inhaled Insulin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... ... May 22, 2017 , ... Patients who avoid necessary dental ... sedation dentistry in Mt. Kisco, NY from Advanced Endodontics of Westchester. This highly-trained team ... of treatments. One or more sedation methods may be recommended based on the severity ...
(Date:5/22/2017)... (PRWEB) , ... May 22, 2017 , ... “Homeostasis: The ... experience learning to live with Bipolar 1. Donald Rodriguez takes readers on a rollercoaster ... Alaska in the dead of winter and to a dark place where Donald considers ...
(Date:5/22/2017)... IL (PRWEB) , ... May 22, 2017 , ... ... is part of a larger group investing in InsightRX, an early stage company ... patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund acted ...
(Date:5/21/2017)... ... May 20, 2017 , ... Pixel Film Studios presents ... use in Final Cut Pro X. The business-oriented elements and dignified animations are ... ProParagraph Corporate will deliver a professional and distinguished look to any multi-line text ...
(Date:5/21/2017)... ... May 21, 2017 , ... For more than 20 ... a wide range of knives and swords, from functional to fantasy. United Cutlery has ... with sleek, modern designs that defy tradition. , Offering a range of weapons and ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... BURNIE, Md. , May 10, 2017 ... retention solutions for the clinical research industry, is proud ... www.CSSiEnroll.com . The new website features both enriched ... overall user experience and enhances the company,s already well-established ... the industry. "After many months of ...
(Date:5/9/2017)... , May 9, 2017  Demonstrating its commitment ... of directors for the Pharmaceutical Research and Manufacturers ... membership. Biopharmaceutical companies will now have to meet ... to be eligible to join PhRMA. ... board is sending a clear message that being ...
(Date:5/9/2017)... , May 9, 2017  Semler Scientific, ... provides technology solutions to improve the clinical effectiveness ... results for the first quarter ended March 31, ... products enable our customers to identify when preventive ... intervene before events like heart attacks or strokes ...
Breaking Medicine Technology: